| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 08/23/2006 | EP1692294A2 Vectors, mutant viruses and methods for generating mutant viruses |
| 08/23/2006 | EP1692293A2 Adenovirus-transfected primary cells and methods of pathway mapping |
| 08/23/2006 | EP1692284A1 Anti-apoptotically active apatamers |
| 08/23/2006 | EP1692267A2 Methods of organ regeneration |
| 08/23/2006 | EP1692154A1 Reduction of dermal scarring |
| 08/23/2006 | EP1692153A2 Inhibition of syk kinase expression |
| 08/23/2006 | EP1691891A2 Inhibition of trp channels as a treatment for cardiac hypertrophy and heart failure |
| 08/23/2006 | EP1691844A1 Methods and compositions for treatment of interferon-resistant tumors |
| 08/23/2006 | EP1691843A1 Ocular tissue modification |
| 08/23/2006 | EP1691842A1 Treatment of proliferative diseases using an antisense iap oligomer and chemotherapeutic agent |
| 08/23/2006 | EP1691817A2 NF-kB OLIGONUCLEOTIDE DECOY MOLECULES |
| 08/23/2006 | EP1691791A2 Capsules of multilayered neutral polymer films associated by hydrogen bonding |
| 08/23/2006 | EP1691780A2 Gene delivery mediated by liposome-dna complex with cleavable peg surface modification |
| 08/23/2006 | EP1691746A2 Mucoadhesive drug delivery devices and methods of making and using thereof |
| 08/23/2006 | EP1691715A2 Surfactant-based gel as an injectable, sustained drug delivery vehicle |
| 08/23/2006 | EP1691609A1 Delivery of viral vectors to extravascular parenchymal cells |
| 08/23/2006 | EP1315537B1 System for myocardial infarction repair |
| 08/23/2006 | EP1276867B1 Use of human latrophilin-like G protein-coupled receptor in screening methods |
| 08/23/2006 | EP1240344B1 Replication incompetent herpes viruses for use in gene therapy |
| 08/23/2006 | EP1190079B1 Control of gene expression in eukaryotic cells |
| 08/23/2006 | CN1823274A Method for diagnosing endometriosis-related disease in womb |
| 08/23/2006 | CN1823161A Reversibly immortalised olfactory ensheathing glia and their use to promote neuronal regenaration |
| 08/23/2006 | CN1821403A Gene up regulation expressed by hepatitis B virus X antigen and its coded product and use |
| 08/23/2006 | CN1820785A Anti-tumor medicine |
| 08/23/2006 | CN1820784A Tobacco expressed foot-and-moath disease plant gene engineering vaccine and its preparing method |
| 08/22/2006 | US7094887 UDP-N-acetylglucosamine: galactose-β1,3-N-acetylgalactosamine-α-R(GlcNAc to GalNAc) β1,6-N-acetylglucosaminyltransferase, C2GnT3 |
| 08/22/2006 | US7094877 Protein for use in treatment of inflammation, nervous system, pain, arthritic and skin disorders |
| 08/22/2006 | US7094876 Human cDNAs and proteins and uses thereof |
| 08/22/2006 | US7094767 Polynucleotide herpes virus vaccine |
| 08/22/2006 | US7094756 relates to the surprising finding that overexpression of ABIN prevents TNF-induced lethal hepatitis in mice |
| 08/22/2006 | US7094603 Transgenic human cells expressing superantigens/antiproliferative agents for use as gene therapeutic tools in cancer treatment ; tissue engineering |
| 08/22/2006 | US7094599 Therapeutic cells which express a membrane-bound, chimeric, proteinaceous receptor comprising an extracellular CD4 fragment to bind an HIV-infected cell without contracting the infection and an intracellular portion to destroy it |
| 08/22/2006 | US7094598 gene expression vectors comprising enhancers having sequence identity to dna sequences, that elicit immune responses against viral disease |
| 08/22/2006 | US7094597 Vaccine compositions and methods useful in inducing immune protection against arthritogenic peptides involved in the pathogenesis of rheumatoid arthritis |
| 08/22/2006 | US7094583 mixtures of dextrins and sugars used for enhanced delivery of eucaryotic expression vectors, to cells in vivo; gene therapy |
| 08/22/2006 | US7094577 Insulin and albumin fusion protein |
| 08/22/2006 | US7094569 Polypeptide for use in the treatment and prevention of alopecia |
| 08/22/2006 | US7094556 Diagnosis and treatment of malignant neoplasms |
| 08/22/2006 | US7094546 screening gene expression inhibition via incubating mrna, determining expression in presence of test compound, then comparing levels; gene knockout |
| 08/22/2006 | US7094535 Nucleic acid ligands to integrins |
| 08/22/2006 | US7094529 Detecting preferential enzyme inhibitors; obtain cell extracts contain caspase, incubate with activator and test inhibitor, measure caspase activation, reduced caspase activation, indicates enzyme inhibitor |
| 08/22/2006 | US7094411 Avirulent, immunogenic flavivirus chimeras |
| 08/22/2006 | US7094410 DNA vaccine against proliferating endothelial cells and methods of use thereof |
| 08/22/2006 | US7094400 Transkaryotic implantation |
| 08/22/2006 | US7094399 Use of spliceosome mediated RNA trans-splicing to confer cell selective replication to adenoviruses |
| 08/22/2006 | US7094201 System and method for genetically treating cardiac conduction disturbances |
| 08/22/2006 | CA2044468C Canine granulocyte macrophage colony stimulating factor |
| 08/17/2006 | WO2006086746A2 Homogeneous neural precursor cells |
| 08/17/2006 | WO2006086667A2 Antisense composition and method for treating muscle atrophy |
| 08/17/2006 | WO2006086559A1 Self-cure activator |
| 08/17/2006 | WO2006086496A2 Stem cell-derived factors for treating pathologic conditions |
| 08/17/2006 | WO2006086454A2 Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms |
| 08/17/2006 | WO2006086105A2 Methods and compositions for treating intervertebral disc disorders |
| 08/17/2006 | WO2006085983A2 Viral adjuvants |
| 08/17/2006 | WO2006085942A2 Compositions and methods for regulating gene transcription |
| 08/17/2006 | WO2006085899A2 Method for enhancing production of isoprenoid compounds |
| 08/17/2006 | WO2006085689A1 Anticancer agent to be combined with telomelysin |
| 08/17/2006 | WO2006085664A1 Polycation chargeable polymer and use as carrier of nucleic acid |
| 08/17/2006 | WO2006085648A1 Novel narcolepsy-related gene |
| 08/17/2006 | WO2006085451A1 Method for reconstruction of blood cell from gene-transferred hematopoietic cell |
| 08/17/2006 | WO2006084746A1 Replication-deficient rna viruses as vaccines |
| 08/17/2006 | WO2006084333A1 Neuroprotective agents and methods of their use |
| 08/17/2006 | WO2006062637A3 Influenza vaccination |
| 08/17/2006 | WO2006060641A3 Methods for targeted delivery of genetic material to the liver |
| 08/17/2006 | WO2006033859A3 Compositions and methods for protein production |
| 08/17/2006 | WO2006016238A3 Capsules containing transfected cells, method for preparing the same and uses thereof for immunization and vaccination |
| 08/17/2006 | WO2005120520A3 Compositions and methods for diagnosis and treatment of chemotherapy-resistant neoplastic disease |
| 08/17/2006 | WO2005111072A3 Notch-based fusion proteins and uses thereof |
| 08/17/2006 | WO2005049845A9 Oncolytic herpes simplex virus encoding a heterologous nitroreductase |
| 08/17/2006 | WO2004089284A8 Targets for tumor growth inhibition |
| 08/17/2006 | WO2003088904A3 Screening and therapeutic methods for treating circadian rhythm disorders |
| 08/17/2006 | US20060185027 Systems and methods for identifying miRNA targets and for altering miRNA and target expression |
| 08/17/2006 | US20060185026 Atypical protein kinase c isoforms in disorders of the nervous system and cancer |
| 08/17/2006 | US20060185025 Human artificial chromosome (hac) vector |
| 08/17/2006 | US20060183713 Compositions of low molecular weight heparin produced with modified heparinase III |
| 08/17/2006 | US20060183708 Topical Delivery of Trace Metals for Enzyme Modulation |
| 08/17/2006 | US20060183705 Immunoglobins; antibodies; immunogens; hepatitis b surface antigens |
| 08/17/2006 | US20060183704 Method to inhibit cell growth using oligonucleotides |
| 08/17/2006 | US20060183703 Circular expression construct for gene therapeutic applications |
| 08/17/2006 | US20060183702 Aptamers to von Willebrand factor and their use as thrombotic disease therapeutics |
| 08/17/2006 | US20060183701 Methods and compositions for determining non-specific cytotoxicity of a transfection agent |
| 08/17/2006 | US20060183700 Cgrp binding nucleic acids |
| 08/17/2006 | US20060183699 Immunoglobins; antibodies; immunogens; hepatitis b surface antigens |
| 08/17/2006 | US20060183676 Treatment of mycobacterium tuberculosis with antisense oligonucleotides |
| 08/17/2006 | US20060183674 Compositions and methods for treating diabetes |
| 08/17/2006 | US20060183229 Regulatory constructs comprising intron 3 of prostate specific membrane antigen gene |
| 08/17/2006 | US20060183199 polynucleotide encoding peptide domain of CD40 ligand lacking a matrix metalloproteinase cleavage sites, used as immunology modulators, vaccines and treatments of human diseases, including malignancies and autoimmune diseases |
| 08/17/2006 | US20060183194 Heregulin variants |
| 08/17/2006 | US20060183192 Modulation of sodium channels in dorsal root ganglia |
| 08/17/2006 | US20060183116 Identifying an inhibitor of cysteine glucosaminyl inositol ligase; drug screening; for treatment of actinomycete infections in mammals using antibiotics that inhibit production or activity of the enzymes of mycothiol biosynthesis, in particular MshC, MshD or MshA |
| 08/17/2006 | US20060182795 containing a polymer, a therapeutic agent, and a complexing agent, where the polymer interacts with the complexing agent in a host-guest or a guest-host interaction to form an inclusion complex; may be used to deliver a therapeutic agent in treatment of various disorders |
| 08/17/2006 | US20060182793 Cpg-packaged liposomes |
| 08/17/2006 | US20060182783 Sustained release intraocular drug delivery systems |
| 08/17/2006 | US20060182759 Novel proteins in enteroaggregative Escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections |
| 08/17/2006 | US20060182758 Novel proteins in enteroaggregative Escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections |
| 08/17/2006 | US20060182757 Polynucleotides, expression vectors, host cells, biosynthesis of polypeptides, generating antibody responses |
| 08/17/2006 | US20060182752 Tri-block polymers for nanosphere-based drug or gene delivery |
| 08/17/2006 | US20060182749 Binding protein; reduce transport activity; killing cells; antiproliferation agents; antitumor agents; anticancer agents; |
| 08/17/2006 | US20060182734 Contacting polysaccharide with disaccharide repeat unit of uronic acid [ alpha -L-iduronic acid or beta -D-glucuronic acid ] linked 1, 4 to alpha -D-hexosamine with mutant heparinase III; sequencing mucopolysaccharides; antitumor, anticarcinogenic and antimetastasis agents; angiogenesis inhibitors |
| 08/17/2006 | US20060182733 ATP diphosphohydrolase (CD39) gene therapy for inflammatory or thrombotic conditions and transplantation and means there for |